These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Drug industry looks to the lab instead of rainforest and reef. Service RF Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712 [No Abstract] [Full Text] [Related]
83. The decline in new drug development. Rumore MM Am Pharm; 1992 Apr; NS32(4):73-8. PubMed ID: 1566739 [TBL] [Abstract][Full Text] [Related]
84. Organic synthesis in flow for medicinal chemistry. Wirth T Bioorg Med Chem; 2017 Dec; 25(23):6179. PubMed ID: 29153554 [No Abstract] [Full Text] [Related]
86. Perspectives in Medicinal Chemistry: The Evolution of Medicinal Chemistry. Bowen JP; Zhong HA Curr Top Med Chem; 2016; 16(9):897-8. PubMed ID: 26510586 [No Abstract] [Full Text] [Related]
88. Enterprising drug company offers cash for chemicals. Adam D Nature; 2001 Aug; 412(6847):575. PubMed ID: 11493887 [No Abstract] [Full Text] [Related]
89. New frontiers for encapsulation in the chemical industry. Andrade B; Song Z; Li J; Zimmerman SC; Cheng J; Moore JS; Harris K; Katz JS ACS Appl Mater Interfaces; 2015 Apr; 7(12):6359-68. PubMed ID: 25764282 [TBL] [Abstract][Full Text] [Related]
90. Medicinal Chemists of the 21(st) Century--Who Are We and Where to Go? Nussbaumer P ChemMedChem; 2015 Jul; 10(7):1133-9. PubMed ID: 25924977 [TBL] [Abstract][Full Text] [Related]
91. Preface: Engineering of pharmaceutical cocrystals, salts and polymorphs: Advances and Challenges. Douroumis D; Nokhodchi A Adv Drug Deliv Rev; 2017 Aug; 117():1-2. PubMed ID: 29103527 [No Abstract] [Full Text] [Related]
93. Steve Carney talks to Mark Ashton and Mark Whittaker about Evotec and their approach to fragment-based drug discovery. Ashton M; Whittaker M Drug Discov Today; 2007 Oct; 12(19-20):789-93. PubMed ID: 18019952 [No Abstract] [Full Text] [Related]
94. Taking the lead? Hird N Drug Discov Today; 2003 Apr; 8(7):292-3. PubMed ID: 12654539 [No Abstract] [Full Text] [Related]
95. MCRs: changing the chemists' mindset. Hird N Drug Discov Today; 2002 Jun; 7(12):649. PubMed ID: 12110239 [No Abstract] [Full Text] [Related]
96. An interview with Maria L. Garcia, Ph.D., Senior Investigator, Merck Research Laboratories. Garcia ML Assay Drug Dev Technol; 2003 Oct; 1(5):605-10. PubMed ID: 15090232 [No Abstract] [Full Text] [Related]
97. [The death of drug safety and compliance?]. Hennemann A Med Monatsschr Pharm; 2002 Apr; 25(4):109. PubMed ID: 11980322 [No Abstract] [Full Text] [Related]
98. Rob Ashley of AmpliMed discusses the discovery and development of Imexon. Interview by Steve Carney. Ashley RA Drug Discov Today; 2005 Oct; 10(20):1339-42. PubMed ID: 16253868 [No Abstract] [Full Text] [Related]
99. New advances in drug discovery. Macphee C Expert Opin Investig Drugs; 2004 Sep; 13(9):1213-5. PubMed ID: 15330753 [TBL] [Abstract][Full Text] [Related]
100. Chemoproteomics as a basis for post-genomic drug discovery. Beroza P; Villar HO; Wick MM; Martin GR Drug Discov Today; 2002 Aug; 7(15):807-14. PubMed ID: 12546968 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]